HHS, Walgreens partner on 1st decentralized COVID shot trial

Walgreens has received $25 million in federal funding to conduct a decentralized clinical trial on COVID-19 vaccine immunity. 

Advertisement

About 20 Walgreens stores in geographically diverse regions across the U.S. will serve as clinical trial sites. This approach aims to increase access to clinical trials and create a more diverse pool of research participants. 

The Biomedical Advanced Research and Development Authority is providing the funding as part of Project NextGen. The $5 billion initiative led by HHS’ Administration for Strategic Preparedness and Response aims to develop public-private partnerships to create more effective, longer-lasting COVID-19 vaccines and treatments. 

The agreement is BARDA’s first partnership with a major retail pharmacy to use a decentralized clinical trial approach. 

Learn more here.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.